Short Report: Complications Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy

por Scanlon, P H, Aldington, S J, Stratton, I M
Publicado 2014

The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial

por Scanlon, P H, Loftus, J, Starita, C, Stratton, I M
Publicado 2015

The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme

por Oke, J. L., Stratton, I. M., Aldington, S. J., Stevens, R. J., Scanlon, P. H.
Publicado 2016

Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age

por Scanlon, P. H., Stratton, I. M., Bachmann, M. O., Jones, C., Leese, G. P.
Publicado 2016

Factors determining uptake of diabetic retinopathy screening in Oxfordshire

por Moreton, R. B. R., Stratton, I. M., Chave, S. J., Lipinski, H., Scanlon, P. H.
Publicado 2017

Attitudes, access and anguish: a qualitative interview study of staff and patients’ experiences of diabetic retinopathy screening

por Hipwell, A E, Sturt, J, Lindenmeyer, A, Stratton, I, Gadsby, R, O'Hare, P, Scanlon, P H
Publicado 2014

Screening attendance, age group and diabetic retinopathy level at first screen

por Scanlon, P. H., Stratton, I. M., Leese, G. P., Bachmann, M. O., Land, M., Jones, C., Ferguson, B
Publicado 2015

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease

por Gale, R, Scanlon, P H, Evans, M, Ghanchi, F, Yang, Y, Silvestri, G, Freeman, M, Maisey, A, Napier, J
Publicado 2017